The Impact of Protein Intake on Protein Metabolism During Intensified Training

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT02801344
Collaborator
Ajinomoto Co., Inc. (Industry)
12
1
3
21.1
0.6

Study Details

Study Description

Brief Summary

Protein requirements in individuals who participate in endurance-based exercise training have been suggested to be greater than the current recommended dietary allowance (RDA).

Our recent study using the minimally invasive indicator amino acid oxidation (IAAO) technique have suggested that protein requirements in young men are at least 30% higher than the recommended protein intake.

The present study will investigate the impact of protein sufficiency on protein metabolism and performance during intensified training periods as a means to further our understanding of the nutritional requirements for the endurance athlete.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Normal
  • Dietary Supplement: Moderate
  • Dietary Supplement: High
  • Other: Controlled-diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Impact of Protein Intake on Amino Acid and Protein Metabolism, and Performance During Intensified Training
Study Start Date :
May 1, 2016
Actual Primary Completion Date :
Sep 1, 2017
Actual Study Completion Date :
Feb 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Normal protein intake

participants will receive the controlled-diet containing 0.8 g protein /kg/day and the test drink containing 0.14 g protein/kg/d.

Dietary Supplement: Normal
test drink which contains low amount of amino acids (0.14 g/kg/day)

Other: Controlled-diet
the diet containing 0.8 g protein /kg/day

Experimental: Moderate protein intake

participants will receive the controlled-diet containing 1.20 g protein /kg/day and the test drink containing 0.40 g protein/kg/d.

Dietary Supplement: Moderate
test drink which contains moderate amount of amino acids (0.40 g/kg/day)

Other: Controlled-diet
the diet containing 0.8 g protein /kg/day

Experimental: High protein intake

participants will receive the controlled-diet containing 1.83 g protein /kg/day and the test drink containing 1.03 g protein/kg/d.

Dietary Supplement: High
test drink which contains high amount of amino acids (1.03 g/kg/day)

Other: Controlled-diet
the diet containing 0.8 g protein /kg/day

Outcome Measures

Primary Outcome Measures

  1. Change in 24h whole body protein balance [Difference between day 1 and day 4 whole body protein balance]

    Protein balance (mg/kg/d; protein synthesis - protein breakdown) will be measured using [15N]Glycine method on day 1 and day 4 to determine the change over the intensified training period to compare between protein levels

Secondary Outcome Measures

  1. Change from baseline physical performance (5 km time trial) 5days after the beginning of training [5days after the beginning of training]

    Before and after 4 days of intensified training period, Duration (seconds) for completing 5-km running on treadmill will be measured.

  2. change from baseline Physical performance (muscle strength) 5days after the beginning of training [5days after the beginning of training]

    Maximal strength will be assessed by a maximal isometric voluntary contraction (MVC), which will be tested for the knee-extensors using a custom-made knee-extension apparatus after 4 days intensified training.

  3. change from baseline Physical Performance (muscle power) 5days after the beginning of training [5days after the beginning of training]

    Peak lower body power will be measured by force platform after 4days-intensified training.

Other Outcome Measures

  1. Creatine Phosphate Kinase activity on day 5 [5days after the beginning of training]

    Muscle damage markers (blood Creatine Phosphate Kinase activity, IU/L) will be compared between the experimental arms 5days after the beginning of training

  2. Myoglobin concentration on day 5 [5days after the beginning of training]

    Muscle damage markers (blood Mb Concentration, mg/mL) will be compared between the experimental arms 5days after the beginning of training

  3. IL-6 concentration on day 5 [5days after the beginning of training]

    inflammatory markers (IL-6 concentration, pg/ml) will be compared between the experimental arms 5days after the beginning of training

  4. CRP concentration on day 5 [5days after the beginning of training]

    inflammatory markers (CRP concentration, mg/L) will be compared between the experimental arms 5days after the beginning of training

  5. amino acid concentration on day 5 [5days after the beginning of training]

    amino acid concentration (mmol/mL) will be compared between the experimental arms 5days after the beginning of training

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy, male, endurance-trained participants who have run regularly more than 45 km or 4.5 hours/week

  • Participants who are categorized at least "very good" based on a study by Shvartz & Reibold [40], in which peak rate of oxygen consumption(VO2 Peak) is used as an index. (i.e. the participants whose VO2peak is ≥57 ml/kg/min (18-24 y), ≥54 ml/kg/min (25-29 y), ≥52 ml/kg/min (30-34 y), ≥49 ml/kg/min (35-39 y), ≥47 ml/kg/min (40-44 y), ≥44 ml/kg/min (45-50 y) according to his age,

  • Participants who can cover 10 km in less than 60 min after the VO2peak test and 5 km Time trial on session 2.

  • Participants will be 18-50 years old.

  • Participants are willing to abide by the compliance rules of this study

Exclusion Criteria:
  • Inability to meet health and physical activity guidelines according to the The Physical Activity Readiness Questionnaire for everyone.

  • Female

  • Inability to adhere to any of the compliance rules judged by principal investigator or medical doctor

  • Regular tobacco use

  • Illicit drug use (e.g. growth hormone, testosterone, etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Goldring Centre For High Performance Sport Toronto Ontario Canada M5S 2C9

Sponsors and Collaborators

  • University of Toronto
  • Ajinomoto Co., Inc.

Investigators

  • Principal Investigator: Daniel Moore, Ph.D., Faculty of Kinesiology and Physical Education, University of Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniel Moore, Associate professor, University of Toronto
ClinicalTrials.gov Identifier:
NCT02801344
Other Study ID Numbers:
  • PFE
First Posted:
Jun 15, 2016
Last Update Posted:
Mar 29, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Daniel Moore, Associate professor, University of Toronto

Study Results

No Results Posted as of Mar 29, 2019